Supplementation with l-carnitine does not reduce the efficacy of epirubicin treatment in breast cancer cells

Cancer Letters

Volumn 252, Issue 2, 2007, Pages 195-207

  Delaney, Christie E ^a   Hopkins, Sean P ^b   Addison, Christina L ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Breast cancer; Chemotherapy; Epirubicin; l Carnitine

Indexed keywords

CARNITINE; EPIRUBICIN;

AEROBIC METABOLISM; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER PATIENT; CARDIOTOXICITY; CELL VIABILITY; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VITAMIN SUPPLEMENTATION;

ANTIBIOTICS, ANTINEOPLASTIC; BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CARNITINE; CELL LINE, TUMOR; DNA PRIMERS; EPIRUBICIN; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34249299054     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.12.027     Document Type: Article

References (48)

1. A'Hern R.P., Smith I.E., and Ebbs S.R. Br. J. Cancer 67 (1993) 801-805
2. Early Breast Cancer Trialists' Collaborative Group, Lancet 352 (1998) 930-942.
3. Cersosimo R.J., and Hong W.K. J. Clin. Oncol. 4 (1986) 425-439
4. Ettinghausen S.E., Bonow R.O., Palmeri S.T., Seipp C.A., Steinberg S.M., White D.E., and Rosenberg S.A. Arch. Surg. 121 (1986) 1445-1451
5. Von Hoff D.D., Layard M.W., Basa P., Davis Jr. H.L., Von Hoff A.L., Rozencweig M., and Muggia F.M. Ann. Intern. Med. 91 (1979) 710-717
6. Praga C., et al. Cancer Treat. Rep. 63 (1979) 827-834
7. Lefrak E.A., Pitha J., Rosenheim S., and Gottlieb J.A. Cancer 32 (1973) 302-314
8. Von Hoff D.D., Rozencweig M., Layard M., Slavik M., and Muggia F.M. Am. J. Med. 62 (1977) 200-208
9. Bristow M.R., Billingham M.E., Mason J.W., and Daniels J.R. Cancer Treat. Rep. 62 (1978) 873-879
10. Friedman M.A., Bozdech M.J., Billingham M.E., and Rider A.K. JAMA 240 (1978) 1603-1606
11. Gianni L., et al. J. Clin. Oncol. 13 (1995) 2688-2699
12. Gehl J., Boesgaard M., Paaske T., Vittrup Jensen B., and Dombernowsky P. Ann. Oncol. 7 (1996) 687-693
13. Cottin Y., et al. Clin. Cardiol. 21 (1998) 665-670
14. Lahtinen R., Kuikka J., Nousiainen T., Uusitupa M., and Lansimies E. Eur. J. Haematol. 46 (1991) 301-305
15. Jain K.K., et al. J. Clin. Oncol. 3 (1985) 818-826
16. Torti F.M., et al. Cancer Res. 46 (1986) 3722-3727
17. Meinardi M.T., et al. Heart 88 (2002) 81-82
18. Wouters K.A., Kremer L.C., Miller T.L., Herman E.H., and Lipshultz S.E. Br. J. Haematol. 131 (2005) 561-578
19. Lipshultz S.E., et al. N. Engl. J. Med. 351 (2004) 145-153
20. Minotti G., Menna P., Salvatorelli E., Cairo G., and Gianni L. Pharmacol. Rev. 56 (2004) 185-229
21. Seymour L., Bramwell V., and Moran L.A. Cancer Prev. Control 3 (1999) 145-159
22. Swain S.M., et al. J. Clin. Oncol. 15 (1997) 1318-1332
23. Yaris N., Ceviz N., Coskun T., Akytuz C., and Buyukpamukcu M. J. Exp. Clin. Cancer Res. 21 (2002) 165-170
24. Pepine C.J. Clin. Ther. 13 (1991) 2-21 discussion 1
25. Walter J.H. Arch. Dis. Child 74 (1996) 475-478
26. Waber L.J., Valle D., Neill C., DiMauro S., and Shug A. J. Pediatr. 101 (1982) 700-705
27. Winter S.C., Szabo-Aczel S., Curry C.J., Hutchinson H.T., Hogue R., and Shug A. Am. J. Dis. Child 141 (1987) 660-665
28. Siliprandi N., Sartorelli L., Ciman M., and Di Lisa F. Clin. Chim. Acta 183 (1989) 3-11
29. Sayed-Ahmed M.M., Shaarawy S., Shouman S.A., and Osman A.M. Pharmacol. Res. 39 (1999) 289-295
30. Abdel-aleem S., el-Merzabani M.M., Sayed-Ahmed M., Taylor D.A., and Lowe J.E. J. Mol. Cell. Cardiol. 29 (1997) 789-797
31. Andrieu-Abadie N., Jaffrezou J.P., Hatem S., Laurent G., Levade T., and Mercadier J.J. FASEB J. 13 (1999) 1501-1510
32. Al-Majed A.A., Sayed-Ahmed M.M., Al-Yahya A.A., Aleisa A.M., Al-Rejaie S.S., and Al-Shabanah O.A. Pharmacol. Res. 53 (2006) 278-286
33. Gramignano G., et al. Nutrition 22 (2006) 136-145
34. Cruciani R.A., et al. Ann. N.Y. Acad. Sci. 1033 (2004) 168-176
35. Bonneterre J., et al. J. Clin. Oncol. 22 (2004) 3070-3079
36. Seidman A., et al. J. Clin. Oncol. 20 (2002) 1215-1221
37. Feldman A.M., Lorell B.H., and Reis S.E. Circulation 102 (2000) 272-274
38. Yaris N., Akyuz C., Coskun T., and Buyukpamukcu M. Pediatr. Hematol. Oncol. 19 (2002) 1-8
39. Mijares A., and Lopez J.R. Eur. J. Pharmacol. 425 (2001) 117-120
40. Alberts D.S., Peng Y.M., Moon T.E., and Bressler R. Biomedicine 29 (1978) 265-268
41. Gurlek A., Tutar E., Akcil E., Dincer I., Erol C., Kocaturk P.A., and Oral D. Eur. J. Heart Fail. 2 (2000) 189-193
42. Ryberg M., Nielsen D., Skovsgaard T., Hansen J., Jensen B.V., and Dombernowsky P. J. Clin. Oncol. 16 (1998) 3502-3508
43. Azab S.S., El-Demerdash E., Abdel-Naim A.B., Youssef E., El-Sharkawy N., and Osman A.M. Biochem. Pharmacol. 70 (2005) 725-732
44. Zoli W., et al. Clin. Cancer Res. 10 (2004) 1500-1507
45. Bartkowiak D., Hemmer J., and Rottinger E. Cancer Chemother. Pharmacol. 30 (1992) 189-192
46. Waldner R., Laschan C., Lohninger A., Gessner M., Tuchler H., Huemer M., Spiegel W., and Karlic H. J. Cancer Res. Clin. Oncol. 132 (2006) 121-128
47. Peluso G., Nicolai R., Reda E., Benatti P., Barbarisi A., and Calvani M. J. Cell Physiol. 182 (2000) 339-350
48. Wenzel U., Nickel A., and Daniel H. J. Nutr. 135 (2005) 1510-1514